Marking World Cancer Day 2025, this week's Executive Q&A is with Diego Santoro, General Manager & Head of International ...
Sartorius Stedim Biotech's Board proposes a dividend of 0.69 euros per share for the fiscal year 2024, with two new Board candidates named. AGM scheduled for March 25, 2025 ...
Kite Pharma’s share price has dived after it emerged that a patient has died from cerebral oedema while being treated with its CAR-T therapy, KTE-C19. Investors were spooked by the news ...
Mayur Ian Somaiya, Chief Financial Officer of NewAmsterdam Pharma Co N.V. (NASDAQ:NAMS), a $2.24 billion market cap pharmaceutical company, recently executed several transactions involving the ...
NAARDEN, The Netherlands and MIAMI, Jan. 29, 2025 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical ...
(MENAFN- GlobeNewsWire - Nasdaq) NAARDEN, The Netherlands and MIAMI, Jan. 29, 2025 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or ...
NAARDEN, The Netherlands and MIAMI, Jan. 29, 2025 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical ...
Here’s a riddle for you: what weighs 250 kilos, is two metres high, and features in around 6,000 selfies a day? The I amsterdam letters, of course! The iconic red and white blocks stood proudly on ...
Royal Bank of Canada reiterated their outperform rating on shares of NewAmsterdam Pharma (NASDAQ:NAMS – Free Report) in a research report report published on Friday morning,Benzinga reports.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results